Mallinckrodt’s Terlipressin Narrowly Clears US FDA Panel As Need For Liver Treatment Outweighs Safety Worries

 
• By Brenda Sandburg

Advisory committee votes 8-7 to recommend approval for terlipressin to treat HRS-1 but is critical of Mallinckrodt’s plan to mitigate the risk of respiratory failure.

Liver
Mallinckrodt's terlipressin for hepatorenal syndrome gets nod from FDA panel • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers